Two Sigma Advisers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Two Sigma Advisers’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-568,749	Closed	-$7.08M	–	2571
2016 Q4	$7.08M	Buy	568,749 +393,200	+224%	+$4.74M	0.03%	589
2016 Q3	$2.4M	Buy	+175,549	New	+$1.76M	0.01%	957
2016 Q2	–	Sell	-15,200	Closed	-$97K	–	2287
2016 Q1	$97K	Sell	15,200 -1,800	-11%	-$10.1K	﹤0.01%	1942
2015 Q4	$106K	Sell	17,000 -32,649	-66%	-$214K	﹤0.01%	1766
2015 Q3	$290K	Sell	49,649 -93,801	-65%	-$723K	﹤0.01%	1517
2015 Q2	$1.19M	Buy	143,450 +57,001	+66%	+$504K	0.01%	1050
2015 Q1	$712K	Sell	86,449 -6,500	-7%	-$48.1K	0.01%	1204
2014 Q4	$639K	Buy	+92,949	New	+$581K	﹤0.01%	1449

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Two Sigma Advisers's ARIA Position: Q1 2017 in Review

Two Sigma Advisers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 568,749 shares — an estimated $7.08M sold.

Two Sigma Advisers first reported a position in ARIA in Q4 2014 and held it in 8 quarters. The position peaked at $7.08M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Two Sigma Advisers reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Two Sigma Advisers sold 568,749 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $7.08M.
Two Sigma Advisers first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 8 quarters.
Two Sigma Advisers's Ariad Pharmaceuticals Inc position peaked at $7.08M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Two Sigma Advisers's 13F filing for Q1 2017, filed 15 May 2017.